Searched for
ASTRAZENECA STOCK PERFORMANCE
AstraZeneca 'magic' faces rare test after trial failure, share slideAstraZeneca's nerve drug Wainua unexpectedly failed a late-stage heart disease trial. This setback has caused investor concern and impacted...- Natco Pharma shares surge 5% after US FDA's tentative nod Olaparib tabletsNatco Pharma shares rose sharply on Monday after the U.S. FDA granted tentative approval for its generic Olaparib tablets, a bioequivalent ...
- Global Market: European shares rebound as tech stocks recover; investors assess Middle East developmentsEuropean stock markets traded higher on Thursday, recovering from previous losses. Technology shares led the gains, driven by renewed inter...
- Walmart to join Nasdaq-100, replacing AstraZeneca from January 20Walmart will replace AstraZeneca in the Nasdaq-100 Index on January 20 following its move from the NYSE. The shift aligns with Walmart’s st...
- AstraZeneca Pharma India shares rise over 2% after CDSCO clears Imfinzi for new cancer useAstraZeneca Pharma India shares saw a rise after Imfinzi got approval for expanded use. The CDSCO approved it as a first-line treatment for...
- US pharma stocks gain up to 5% on Trump's move to slash drug pricesPresident Trump plans to sign an executive order mandating drugmakers to align U.S. drug prices with those of other countries, setting pric...
- Bajaj Finance, Angel One, Can Fin Homes among 9 stocks that hit 52-week high on TuesdaySeveral stocks in the S&P BSE 500 index, including Angel One, AstraZeneca Pharma, and Bajaj Finance, achieved new 52-week highs, reflecting...
- Landmark Cars, Force Motors among 8 BSE small cap stocks surge to new 52-week highsSeveral BSE Smallcap stocks reached their 52-week high and generated market excitement. AstraZeneca Pharma, Apar Industries, Force Motors, ...
- Arvind, Kirloskar Industries among 4 stocks near 52-week highSeveral companies in S&P BSE Smallcap stocks have approached their 52-week high levels, including Arvind, Kirloskar Industries, Waaree Rene...
- BSE smallcap stocks in momentum: Arvind, Kirloskar Industries and 4 other stocks near 52-week highSeveral S&P BSE Smallcap stocks, including Arvind, Kirloskar Industries, Waaree Renewable Technologies, AstraZeneca Pharma, Safari Industri...
- Golden Crossover Stocks: 5 companies poised for potential growthETMarkets has identified five stocks with a Golden Crossover, indicating potential growth opportunities. These companies have a market capi...
- AstraZeneca jab uncertainty will hit Oxford BioMedica’s revenueIn a recent report, Oxford Biomedica warned that uncertainty surrounding AstraZeneca’s Covid-19 contract will bring reduction in earnings t...
- AstraZeneca says on track to deliver on Covid shots as sales hit $275 mnWhen including production and distribution from partners such as the Serum Institute of India, more than 300 million doses have been suppli...
- Australia shares slip after government scraps vaccination targetsThe S&P/ASX 200 index slipped 0.3 per cent to 6,974, closing lower for the second straight session. Last week, it had posted its best weekl...
- Australia shares end lower as vaccine rollout hits snagThe S&P/ASX 200 index settled 0.1 per cent lower at 6,995.2 points at close of trade, applying brakes on its longest winning run since earl...
- The CEO who capped a $37 billion recovery with AstraZeneca dealNakayama decided to reboot Daiichi Sankyo, pivoting toward the more lucrative business of cancer drugs.
- AstraZeneca Pharma closes over 3% higher on 3-fold jump in Q1 netThe company said its net sales for the quarter ended June 30 jumped 15.1 per cent YoY to Rs 138.10 crore, compared with Rs 120.03 crore yea...
- Dr Reddy’s sues AstraZeneca over purple colour of Nexium genericAZ had asserted that its purple coloured pill is protected by three federal trademarks and the generic drug launched by Dr Reddy’s in Septe...
- Earnings, ANDA approvals to supplement pharma stocks: Neeraj Deewan, Quantum SecuritiesA continuous improvement in earnings on sequential basis will continue and pharma stocks may keep on performing well, believes Quantum Secu...
- Torrent Pharma to do well in midcap pharma space: Sharmila JoshiET Now caught up with Sharmila Joshi, Co-Head PCG Sales, Emkay Global Financial Services, to get her views on the outlook of Torrent Pharma.
Load More
